| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |